Suvretta Capital Management, LLC Molecular Partners Ag Put Options Transaction History
Suvretta Capital Management, LLC
- $2.39 Billion
- Q2 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding MOLN
# of Institutions
9Shares Held
860KCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA443KShares$2.12 Million0.1% of portfolio
-
Old Mission Capital LLC10.4KShares$49,6480.0% of portfolio
-
Ubs Group Ag3.46KShares$16,5780.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.5KShares$11,9750.0% of portfolio
-
Morgan Stanley New York, NY367Shares$1,7570.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $156M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...